Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release on the unaudited financial results of the Company for the 3rd quarter and nine months ended 31st December, 2023 Krishna Institute of Medical Sciences Ltd - 543308 - Results- Financial Results For The Quarter And Nine Months Period Ended 31St December, 2023
Result- Financial Result for the quarter and nine months period ended 31st December, 2023 Krishna Institute of Medical Sciences Ltd - 543308 - Board Meeting Outcome for Outcome Of Board Meeting Held On 3Rd February 2024 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Outcome of Board Meeting held on 3rd February, 2024 Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dr. Bhaskara Rao Bollineni - Founder & Managing Director, Dr. Abhinay Bollineni - Executive Director and CEO, and Mr. Sachin Salvi - Chief Financial Officer, would participate in a conference call with analysts and investors, being hosted by IIFL Securities on Monday, 5th February 2024, at 09:30 am IST, to discuss the company's business strategy and outlook post the declaration of Q3FY24 financial results. Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Change in Management
End of Term of 5 years of Mr. Rajeswara Rao Gandu, Independent Director of the Company. Krishna Institute of Medical Sciences Ltd - 543308 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund Krishna Institute of Medical Sciences Ltd - 543308 - Board Meeting Intimation for Notice Of Board Meeting
Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2024 ,inter alia, to consider and approve the un-audited (Standalone & Consolidated) financial results of the company for the quarter and nine months ended December 31, 2023. Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Acquisition
Acquiring an additional stake of 5.04% in material subsidiary i.e. Sarvejana Healthcare Private Limited. Krishna Institute of Medical Sciences Ltd - 543308 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 of SEBI(DP) Regulations, 2018 for the quarter ended 31st December, 2023. Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Change in Management
Intimation of completion of Tenure of Mr. Pankaj Vaish as Non-Executive- Independent Director of the Company w.e.f 07-01-2024 at 11:59:59 PM.